These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8539077)

  • 1. [Use of azithromycin in ORL].
    Gehanno P
    Pathol Biol (Paris); 1995 Jun; 43(6):530-3. PubMed ID: 8539077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose extended-release oral azithromycin vs. 3-day azithromycin for the treatment of group A beta-haemolytic streptococcal pharyngitis/tonsillitis in adults and adolescents: a double-blind, double-dummy study.
    Jorgensen DM
    Clin Microbiol Infect; 2009 Dec; 15(12):1103-10. PubMed ID: 19929975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis.
    Cohen R
    Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S129-34. PubMed ID: 14770076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of Streptococcus pyogenes to two macrolides in northern Israel.
    Sakran W; Raz R; Chazan B; Koren A; Colodner R
    Int J Antimicrob Agents; 2004 May; 23(5):517-9. PubMed ID: 15120735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis.
    Casey JR; Pichichero ME
    Clin Infect Dis; 2005 Jun; 40(12):1748-55. PubMed ID: 15909262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
    Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
    Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin versus penicillin V in the treatment of paediatric patients with acute streptococcal pharyngitis/tonsillitis. Paediatric Azithromycin Study Group.
    O'Doherty B
    Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):718-24. PubMed ID: 8922571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolide therapy of group A streptococcal pharyngitis: 10 days of macrolide therapy (clarithromycin) is more effective in streptococcal eradication than 5 days (azithromycin).
    Kaplan EL; Gooch III WM; Notario GF; Craft JC
    Clin Infect Dis; 2001 Jun; 32(12):1798-802. PubMed ID: 11360224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial therapy for acute group a streptococcal pharyngotonsillitis: short-course versus traditional 10-day oral regimens.
    Brook I
    Paediatr Drugs; 2002; 4(11):747-54. PubMed ID: 12390046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Explaining the poor bacteriologic eradication rate of single-dose ceftriaxone in group a streptococcal tonsillopharyngitis: a reverse engineering solution using pharmacodynamic modeling.
    Blumer JL; Reed MD; Kaplan EL; Drusano GL
    Pediatrics; 2005 Oct; 116(4):927-32. PubMed ID: 16199703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolides in the management of streptococcal pharyngitis/tonsillitis.
    Tarlow MJ
    Pediatr Infect Dis J; 1997 Apr; 16(4):444-8. PubMed ID: 9109157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial eradication rates with shortened courses of 2nd- and 3rd-generation cephalosporins versus 10 days of penicillin for treatment of group A streptococcal tonsillopharyngitis in adults.
    Pichichero ME; Casey JR
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):127-30. PubMed ID: 17908614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of normal oropharyngeal flora in the development of streptococcal pharyngitis and outcome of penicillin therapy].
    Mihajlović-Ukropina M; Roncević N
    Med Pregl; 1998; 51(5-6):275-8. PubMed ID: 9720358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rational use of antibiotics in pediatrics: impact of a rapid test for detection of beta-haemolytic group A streptococci in acute pharyngotonsillitis].
    Contessotto Spadetto C; Cámara Simón M; Avilés Inglés MJ; Ojeda Escuriet JM; Cascales Barceló I; Rodríguez Sánchez F
    An Esp Pediatr; 2000 Mar; 52(3):212-9. PubMed ID: 11003896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of eradication of group A beta-hemolytic streptococci in children with pharyngo-tonsillitis by amoxicillin and cefdinir.
    Brook I; Gober AE
    Int J Pediatr Otorhinolaryngol; 2009 May; 73(5):757-9. PubMed ID: 19285734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming penicillin failures in the treatment of Group A streptococcal pharyngo-tonsillitis.
    Brook I
    Int J Pediatr Otorhinolaryngol; 2007 Oct; 71(10):1501-8. PubMed ID: 17644191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.
    Girard D; Finegan SM; Dunne MW; Lame ME
    J Antimicrob Chemother; 2005 Aug; 56(2):365-71. PubMed ID: 16002421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent tonsillitis and pneumonia due to S. pyogenes.
    Papadas TA; Karkoulias KP; Mastronikolis NS; Sampsonas FL; Spiropoulos KB
    Clin Ter; 2008; 159(1):33-4. PubMed ID: 18399260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rational dosing intervals in streptococcal infections of the pharynx].
    Rauchegger H; Picker H; Guggenbichler JP; Allerberger F
    Wien Klin Wochenschr; 1989 Mar; 101(7):230-3. PubMed ID: 2652891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharyngeal A-streptococcal infection encountered in the practical work of an internal medicine specialist].
    Belov BS
    Vestn Otorinolaringol; 2013; (3):39-43. PubMed ID: 23887373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.